Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAL Scientific
Wimborne, England, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
SAL Scientific develops animal component‑free cell growth supplements (InstiGRO, InstiSHAKE, InstiTHAW) that improve growth and cloning efficiency of CHO and HEK cells used to generate production cell lines for monoclonal antibodies and viral vectors; the products support early biologics and gene therapy development workflows but are research reagents rather than therapeutics.[1][3]
- Modalities
- BiologicCell culture media supplementProtein
- Industry
- Non-Drug Biotech
02
Partnerships
Advanced Instruments (distribution and, since 2022, ownership of Insti cell growth supplement portfolio)[1][3]
Beyond the preview
Go deeper on SAL Scientific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SAL Scientific.